2-{[(4-chlorophenyl)methyl]sulfanyl}-4-(2,3-dimethylphenoxy)-5,6,7,8-tetrahydroquinazoline

Catalog No. :
ACEIKP100
CAS No. :
339019-02-2
Molecular Formula :
C23H23ClN2OS
Molecular Weight :
410.97

IUPAC Name:2-((4-chlorobenzyl)thio)-4-(2,3-dimethylphenoxy)-5,6,7,8-tetrahydroquinazoline

2-{[(4-chlorophenyl)methyl]sulfanyl}-4-(2,3-dimethylphenoxy)-5,6,7,8-tetrahydroquinazoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-{[(4-chlorophenyl)methyl]sulfanyl}-4-(2,3-dimethylphenoxy)-5,6,7,8-tetrahydroquinazoline
IUPAC Name2-((4-chlorobenzyl)thio)-4-(2,3-dimethylphenoxy)-5,6,7,8-tetrahydroquinazoline
Molecular FormulaC23H23ClN2OS
Molecular Weight410.97
SMILESCC1=C(C)C(OC2=C3CCCCC3=NC(SCC4=CC=C(Cl)C=C4)=N2)=CC=C1
InChI KeyMZKLDRUGUDPCEV-UHFFFAOYSA-N
Synonym2-[(4-CHLOROBENZYL)SULFANYL]-5,6,7,8-TETRAHYDRO-4-QUINAZOLINYL 2,3-DIMETHYLPHENYL ETHER;2-[(4-CHLOROBENZYL)SULFANYL]-4-(2,3-DIMETHYLPHENOXY)-5,6,7,8-TETRAHYDROQUINAZOLINE;2-{[(4-chlorophenyl)methyl]sulfanyl}-4-(2,3-dimethylphenoxy)-5,6,7,8-tetrahydroquinazoline;Quinazoline, 2-[[(4-chlorophenyl)methyl]thio]-4-(2,3-dimethylphenoxy)-5,6,7,8-tetrahydro-
CAS No.339019-02-2

Synthetic Route by SureRoute

1. ACEIKP100 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEIKP100 route product structure diagram
    ACEIKP100339019-02-2
Inquiry

2. ACEIKP100 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEIKP100 route product structure diagram
    ACEIKP100339019-02-2
Inquiry

Comments (0)